Regulatory T cell dysfunction in type 1 diabetes: what’s broken and how can we fix it?

Por Hull, Caroline M., Peakman, Mark, Tree, Timothy I. M.
Publicado no Diabetologia (2017)

CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK–779

Por Nedjai, Belinda, Viney, Jonathan M, Li, Hubert, Hull, Caroline, Anderson, Caroline A, Horie, Tomoki, Horuk, Richard, Vaidehi, Nagarajan, Pease, James E
Publicado no Br J Pharmacol (2015)

GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells

Por Arif, Sefina, Gomez-Tourino, Iria, Kamra, Yogesh, Pujol-Autonell, Irma, Hanton, Emily, Tree, Timothy, Melandri, Daisy, Hull, Caroline, Wherrett, Diane K., Beam, Craig, Roep, Bart O., Lorenc, Anna, Peakman, Mark
Publicado no Diabetologia (2020)

Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2

Por Reading, James L, Vaes, Bart, Hull, Caroline, Sabbah, Shereen, Hayday, Thomas, Wang, Nancy S, DiPiero, Anthony, Lehman, Nicholas A, Taggart, Jen M, Carty, Fiona, English, Karen, Pinxteren, Jef, Deans, Robert, Ting, Anthony E, Tree, Timothy I M
Publicado no Mol Ther (2015)